Wednesday, February 22, 2012

Colonization model of wild-type (wt) and mutant p.

Streptococus pneumonia is an important human pathogen, but most are those


installs only transitional nasopharyngeal colonization without causing disease. Use


murine model, this thesis examined the hypothesis that colonization creates purchased


immune responses that protect against subsequent pneumonia. Colonization model of wild-type (WT) and mutant S. pneumonia was set


in outbred mice CD1. Mutants lacking or capsules or lipoproteins, or were


auksotrofy can proliferate in vivo. WT colonization is being protected from subsequent pneumonia


. Mutants were cleared faster than the WT, no immunogenicity and


not protect. When auksotrofy was added, colonization,


immunogenicity and protection have been improved, suggesting the duration of colonization event


is an important factor in determining immunogenicity. This may be a factor


explain poor immunogenicity of other mutants. The mechanism by which previous colonization is being protected from subsequent lethal pneumonia >> << then was determined in a series of studies in inbred CBA / Ca mice. Colonization of the mucosa induced as systemic antibodies to bacterial antigens


surface, but not capsule. There was also evidence of more robust cytokine


production over the next pneumonia, including systemic and mucosal IL-17


responses depending on the presence of CD4-cells. Protection was primarily against


system invasion after pneumonia. Passive transfer experiments and research


using genetically modified mice showed that systemic antibodies was


necessary and sufficient for protection, and in vitro and in natural strattera models have shown that this


treatment for atypical pneumonia

opsonophagocytosis through blood and clearance of bacteria. Antigenic protein


purpose of protective serum were determined by Western blot and multiplex bead


ELISA methods. In general, this provision shows that nasal colonization may protect against lethal pneumonia


in mice by opsonophagocytic antibodies against surface proteins so


prevent bacteremia. . << >>

No comments:

Post a Comment